Amy Boyet

Amy Boyet

Chief Compliance Officer

Chief Compliance Officer

Specialized in FINRA compliance, diligence, and operations, Amy is a highly-experienced professional whose experience crosses both technology and finance fields.

After working in basic scientific research for 9 years with the Department of Pathology and Immunology at Washington University in St. Louis, Amy worked in intellectual property management with Washington University in St. Louis’s Office of Technology Management, Biotechnology due diligence and private equity funding with BioGenerator and operations management with Pulse Therapeutics, Inc.

Amy holds a BS in Biology, Cum Laude from Culver-Stockton College, an MS Cellular and Molecular Biology from the University of Missouri-St. Louis, and an MBA from Washington University in St. Louis. Amy is actively involved as an advisor the Washington University’s Biotechnology and Life Science Advising Group. Amy holds Series 79, 63, 27 and 24 securities licenses.

Specialized in FINRA compliance, diligence, and operations, Amy is a highly-experienced professional whose experience crosses both technology and finance fields.

After working in basic scientific research for 9 years with the Department of Pathology and Immunology at Washington University in St. Louis, Amy worked in intellectual property management with Washington University in St. Louis’s Office of Technology Management, Biotechnology due diligence and private equity funding with BioGenerator and operations management with Pulse Therapeutics, Inc.

Amy holds a BS in Biology, Cum Laude from Culver-Stockton College, an MS Cellular and Molecular Biology from the University of Missouri-St. Louis, and an MBA from Washington University in St. Louis. Amy is actively involved as an advisor the Washington University’s Biotechnology and Life Science Advising Group. Amy holds Series 79, 63, 27 and 24 securities licenses.